While the news states that the new weight loss medication Contrave will most likely be approved in September 2014, the struggles the drug has faced so far hint about the challenges obesity drugs have had historically in the U.S. In the last 13 years, only two drugs have been approved by the FDA, including Qsymia and Belviq. [Read more]
15
Jul